Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study ; volume:16 ; number:1 ; day:16 ; month:1 ; year:2014 ; pages:1-9 ; date:2.2014
Arthritis Research & Therapy ; 16, Heft 1 (16.1.2014), 1-9, 2.2014
- Urheber
-
SVENSSON, BJOERN
- Beteiligte Personen und Organisationen
-
HAFSTROEM, INGIAELD
Erlandsson, Malin C.
Forslind, Kristina
Bokarewa, Maria I.
SpringerLink (Online service)
- DOI
-
10.1186/ar4438
- URN
-
urn:nbn:de:1111-2016052321357
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- SVENSSON, BJOERN
- HAFSTROEM, INGIAELD
- Erlandsson, Malin C.
- Forslind, Kristina
- Bokarewa, Maria I.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis
Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study
Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis
Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides
Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis
Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking
Clinical significance of anti-cyclic citrullinated peptide antibodies in Egyptian patients with chronic hepatitis C virus genotype IV infection
Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis
Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study
Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis
Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides
Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis
Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking
Clinical significance of anti-cyclic citrullinated peptide antibodies in Egyptian patients with chronic hepatitis C virus genotype IV infection
Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis
Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study
Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis
Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides
Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis
Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking